Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Cytoki Pharma ApS
APS
In liquidation
Reklamebeskyttelse
CVR 40594132
Vandtårnsvej 77, 2860
Søborg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
3 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cytoki Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AH
Anders Hagstrøm
Unofficial title
Unofficial title
2026
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Former (8)
DB
Daniel Bach Gonzalez
Board of Directors
Board of Directors
2021 – 2024
SJ
Susanne Jørgensen
Board of Directors
Board of Directors
2019 – 2020
AV
Amanda Viven Gett-Chaperot
Board of Directors
Board of Directors
2021 – 2023
KI
Karen Ina Barbara Wagner
Board of Directors
Board of Directors
2021 – 2026
AE
Annegret Elisabeth De Baey-Diepolder
Board of Directors
Board of Directors
2023 – 2026
CE
Christian Ellebæk Elling
Chairman
Chairman
2021 – 2026
RJ
Rasmus Jørgensen
Chairman
Chairman
2019 – 2020
KA
Klaus Andreas Dugi
Board of Directors
Board of Directors
2024 – 2026
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
LUNDBECKFOND INVEST A/S
Company
25–33.32%
25–33.32%
2021
NanoDimension III, L.P
Individual
20–24.99%
20–24.99%
2024
YSIOS Biofund III, F.C.R.E
Individual
15–19.99%
15–19.99%
2024
15-Bio ApS
Company
10–14.99%
10–14.99%
2022
Health for Life Capital II FPCI - ALPHA Compartment
Individual
5–9.99%
5–9.99%
2021
FCPI Bio Sante 2018-2019
Individual
5–9.99%
5–9.99%
2024
Health For Life Capital II Prima S.C.A. RAIF
Individual
5–9.99%
5–9.99%
2021
FCPI Bio Sante 2018-2019
Individual
5–9.99%
5–9.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Cytoki Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network